Endo International | ENDP

Stock Price
0.03
Daily Change
0%
Yearly
-94.89%
Q2 Forecast
0.04
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Takeda 4,468.00 51.00 1.15% 23.46%
AbbVie 136.84 3.43 2.57% -7.02%
Amarin 1.28 0.07 5.79% -23.81%
ANI Pharmaceuticals 48.00 1.58 3.40% 64.16%
Bristol-Myers Squibb 65.66 0.98 1.52% -12.65%
Coherus Biosciences 4.45 0.40 9.88% -41.22%
Endo International 0.03 0 0% -94.89%
Hikma Pharmaceutical 1,803.00 11.00 0.61% 7.64%
Heron Therapeutics 1.12 0.01 0.90% -62.67%
Horizon Pharma 99.93 -0.47 -0.47% 9.46%
Ligand Pharmaceuticals 75.31 4.11 5.77% -11.32%
Eli Lilly 442.22 5.84 1.34% 46.60%
Merck & Co 112.52 1.59 1.43% 25.15%
Novartis 89.37 1.31 1.49% 4.12%
Phibro Animal Health 13.75 0.83 6.42% -26.55%
Pacira 39.09 1.05 2.76% -39.22%
Patterson Companies 27.03 0.76 2.89% -13.09%
Pfizer 38.36 0.34 0.89% -27.89%
Perrigo 32.99 0.93 2.90% -16.18%
Revance Therapeutics 31.06 0.65 2.14% 133.53%
Supernus Pharmaceuticals 33.53 0.57 1.73% 18.56%
Teva Pharmaceutical Industries 2,743.00 63.00 2.35% -12.78%
Xeris Pharmaceuticals 2.82 0.20 7.63% 28.18%
Zoetis 171.88 5.88 3.54% 1.70%

Indexes Price Day Year
USND 13241 139.78 1.07% 10.22%
US400 2506 79.30 3.27% -0.62%

Endo International

Endo International Ordinary Shares traded at $0.03 this Friday June 2nd, decreasing $0 or 0 percent since the previous trading session. Looking back, over the last four weeks, Endo International lost 50.74 percent. Over the last 12 months, its price fell by 94.89 percent. Looking ahead, we forecast Endo International Ordinary Shares to be priced at 0.04 by the end of this quarter and at 0.04 in one year, according to Trading Economics global macro models projections and analysts expectations.

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.